NLRP3 promotes the proliferation and metastasis of colorectal cancer by regulating the S6K1-GLI1 signaling pathway
2025

NLRP3's Role in Colorectal Cancer Growth and Spread

Sample size: 27 publication Evidence: moderate

Author Information

Author(s): Li Si, Wang Xuchao, Hong Li, Zhuang Zirui, Yang Pei, Chen Yu, Yao Yizhou, Jiang Linhua, Zhu Xinguo, Wang Bin

Primary Institution: The First Affiliated Hospital of Soochow University

Hypothesis

NLRP3 promotes the proliferation and metastasis of colorectal cancer by regulating the S6K1-GLI1 signaling pathway.

Conclusion

NLRP3 facilitates CRC progression via the EMT and the S6K1-GLI1 signaling pathway, providing a promising target against CRC patients.

Supporting Evidence

  • Elevated NLRP3 levels in CRC tissue correlated with adverse patient outcomes.
  • Suppressing NLRP3 expression effectively inhibited the proliferation and migration of CRC cells.
  • NLRP3 knockdown significantly reduced tumor growth in mouse models.

Takeaway

NLRP3 is a protein that helps colorectal cancer grow and spread, and blocking it could help treat the disease.

Methodology

The study used qPCR, Western blot, CCK8 assay, Colony formation assay, Transwell assay, and mouse xenografts to assess NLRP3's effects on CRC cells.

Limitations

The study's analysis is based on limited bioinformatics methodologies and a small sample size of clinical CRC patients.

Participant Demographics

Patients were recruited from the First Affiliated Hospital of Soochow University, all having undergone complete radical surgery.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.7150/jca.101285

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication